Michael Serrano Wu News Today

- TTX-810 is designed for rapid clearance to circumvent mechanism-based risks of MCL1 inhibition - High potency affords robust anti-tumor effects whilst preserving cardiomyocyte viability - Trueline

- Key C-suite appointments provide fiscal and culture leadership as company expandsCAMBRIDGE, Mass.--(BUSINESS WIRE)--Anji Pharma, an emerging global medicines company, today announced an expanded leadership team with the appointments of Julianne Averill as Chief Financial Officer and Kristen Richardson as Chief Peo...